general
B cells may play a role in triggering immunotherapy-related colitis
Researchers at The University of Texas MD Anderson Cancer Center have identified a previously unknown role for B cells, which are adaptive immune cells, in triggering and sustaining colitis occurring as a side effect of immune checkpoint inhibitors, a widely used form of cancer immunotherapy.
Researchers at The University of Texas MD Anderson Cancer Center have identified a previously unknown role for B cells, which are adaptive immune cells, in triggering and sustaining colitis occurring as a side effect of immune checkpoint inhibitors, ... [3460 chars]
Read Full ArticleShare this story
Up next
Related Stories
NeuroScientific specialist hire sets stage for major Crohn’s trial
Sydney Morning Herald
Australian woman dies in Vietnam after cosmetic surgery: reports
Sydney Morning Herald
Climate activists banned from entering police ‘fort’ around Perth defence expo
Sydney Morning Herald
Federal Court rules against challenge to SA government's golf course plans
ABC News Australia
Australian couple among passengers on diverted flydubai flight to Israel, embassy says
The Guardian Australia